A federal appeals court ruled last week that all products made from regulated hemp are legal as long as they have a delta-9 THC concentration no greater than 0.3%.
Former President Donald Trump is backing a ballot measure to legalize recreational cannabis in Florida, arguing "medical marijuana has been amazing."
Two influential organizations have endorsed a ballot initiative to legalize recreational cannabis in Florida, giving the reform effort new support.
Republican VP candidate JD Vance claimed that cannabis is tainted with fentanyl, a myth that experts have largely debunked.
California patients, growers, and local leaders come together to oppose a proposed amendment to regulate hemp cannabinoids.
Results from NuggMD.com's poll reveal that while Harris gets a major bump over Biden, Trump still leads among cannabis consumer voting block.
Report finds teens are significantly less likely to use cannabis than before the modern legalization era.
Results from NuggMD's Cannabis Consumer poll on how often consumers shop at licensed dispensaries versus unregulated shops.
After a historic prisoner exchange, medical cannabis patient and teacher Marc Fogel remains in a Russian penal colony.
The recent SCOTUS decision overturning the Chevron Doctrine may have thrown a wrench into rescheduling, but public comments are still vital.
Results from NuggMD.com's strain poll, revealing consumer preferences on reason for cannabis use, desired effects, and flavor and aroma profile.
We explore the most common conditions patients are treating with medical cannabis and what that means for doctors, policymakers, and consumers.
Results from NuggMD.com's 2024 Election Poll, revealing insights into cannabis voter proclivities and their potential impact in 2024 voting.
We tested 18 cannabis products from unlicensed shops around California. What we found should concern anyone without access to licensed dispensaries.
More patients are seeking out information on services that enable them to get their medical cannabis card online. Can search traffic can indicate growth and slowdowns in a market in a way that annual registration reports lack the ability to.
To better understand why patient outcomes and state policies are often in conflict, we surveyed 603 medical cannabis patients who were treating neuropathy as a primary or secondary condition.
With the DEA reconsidering restrictions, we wanted to understand how a change in classification would affect consumers. And that starts with seeing which states are most interested in Delta 8.
Polling data from cannabis users makes an iron-clad case for more progressive, not more restrictive, policy if New York’s cannabis market is going to function in a safe, lawful way.